About Eagle Genomics
Eagle Genomics is a Healthcare company based in Cambridge (United Kingdom) founded in 2008. Developer of cloud-based software solutions for genomic analysis. Eagle Genomics has raised $38.73 million across 9 funding rounds from investors including Gov.uk, Newable and abrdn. Its chief executive, as recorded, is Anthony Finbow. Eagle Genomics offers products and services including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk]. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis. Its legal entity is EAGLE GENOMICS LIMITED.
Company details
Eagle Genomics was founded in 2008 and is based in Cambridge, United Kingdom. Cloud-based software solutions for genomic analysis are provided by the company within the biotechnology sector. Operations focus on platforms such as Eaglecore, which supports collaborative information management in research and development, and EagleEnsembl, which enables searching and analysis of genomic data. Services are delivered through a domain at eaglegenomics.com.
- Headquarters Cambridge, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website eaglegenomics.com
- Social LinkedIn X Facebook
- Legal Name Eagle Genomics Limited
- Date of Incorporation 07 May, 2008
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND
- Annual Revenue$3.35 M (USD)79as on Mar 31, 2022
- Net Profit-$6.88 M (USD)-101as on Mar 31, 2022
- EBITDA-$6.88 M (USD)-101as on Mar 31, 2022
- Total Equity Funding$38.73M (USD)
in 9 rounds
- Latest Funding Round$3.65M (USD), Series C
Sep 2023
- InvestorsGov.uk
& 11 more
Products & Services of Eagle Genomics
Eagle Genomics offers a comprehensive portfolio of products and services, including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk].
Platform for analyzing microbiome data to drive innovation.
Tool for exploring complex microbiome patterns and relationships.
Service for biological data integration in microbiome research.
Application for advanced data science in microbiome contexts.
Kit for developing custom microbiome data applications.
Platform for sharing and accessing microbiome data resources.
Tool for detailed reporting on microbial strains and networks.
Funding Insights of Eagle Genomics
Eagle Genomics has successfully raised a total of $38.73M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $3.65 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.73M
- Total Rounds 9
- Last Round Series C — $3.65M
- First Round $917,698
(Sep 2013)
- Investors Count 12
All 9 funding rounds of Eagle Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $3.65M | Series C | – | ETF Partners | |
| Oct 2022 | $20M | Series C | – | abrdn | |
| Oct 2020 | $9M | Series B | – | ETF Partners, Granpool | |
| Jan 2019 | $3.5M | Series A | – | ETF Partners | |
| Apr 2018 | $1M | Seed | – | – | |
| Feb 2018 | $2.37M | Grant | – | – | |
| Aug 2017 | $782,357 | Grant | – | – | |
| Nov 2013 | $661,000 | Seed | – | London Business Angels | |
| Sep 2013 | $917,698 | Seed | – | UK Innovation Science & Seed Fund |
12 investors in total: 10 institutional and 2 angel.
Investors in Eagle Genomics
Eagle Genomics has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Gov.uk, Newable and abrdn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments in tech and energy sectors are targeted. | etfpartners.capital | London, United Kingdom | ||
Granpool is recognized as a venture capital investment firm. | granpool.com | Luxembourg, Luxembourg | ||
Multiple sectors are invested in by abrdn's private equity fund. | 1825 | abrdn.com | Edinburgh, United Kingdom | |
A Czech family office managing partner families' assets is operated. | 2011 | bpdpartners.cz | Czech Republic | |
Early-stage innovations are funded by UKI2S across key sectors. | ukinnovationscienceseedfund.co.uk | Manchester, United Kingdom | ||
Venture capital firm focused on angel investments | acfinvestors.com | Sheffield, United Kingdom | ||
Angel investment network focused on technology startups in the UK. | 2001 | cambridgecapitalgroup.co.uk | Cambridge, United Kingdom | |
Business loans are provided to UK enterprises by Newable. | 1982 | newable.co.uk | London, United Kingdom | |
Online government services and information are provided to users. | 1707 | gov.uk | London, United Kingdom | |
Delivers comprehensive investment services for businesses. | 1982 | lbangels.co.uk | London, United Kingdom |
Investor details for Eagle Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Eagle Genomics
17 people are tracked at Eagle Genomics (4 in leadership, 7 in board & advisors, 6 in team).
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Rahim Saeidi | Director, Data Science | Leadership |
Sandra Bläser | VP Customer Success | Leadership |
Gopala Vadrevu | Director, Engineering | Leadership |
Jim Frates | Advisor | Board & advisors |
Cliff Meltzer | Chairman | Board & advisors |
Rob Genieser | Director | Board & advisors |
David Cleevely | Advisor | Board & advisors |
Miklós Kóbor | Director | Board & advisors |
Delphine Gény-Stephann | Director | Board & advisors |
Joshua C. Anthony | Advisor | Board & advisors |
Sudheer Karanam | Software engineer | Team |
Dr. Sangita Kumari | Bioinformatics Scientist | Team |
Kseniia Tuholukova | Data Scientist | Team |
Satish Puppala | Frontend Developer | Team |
Yelyzaveta R. | Lead Senior Technical PM | Team |
Carmela Morales | Program Manager | Team |
Complete people profiles for Eagle Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eagle Genomics
3 dated milestones of Eagle Genomics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Eagle Genomics is founded.
- Funding First funding round of $918K.
- Funding Latest funding round, Series C, of $3.7M.
Web traffic of Eagle Genomics
Websites that share an audience with Eagle Genomics (eaglegenomics.com).
Websites whose visitors overlap most with Eagle Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
brc.ncsu.edu | brc.ncsu.edu | 100% | – | ||
| clcbio.com | 83% | View details | |||
isrec.isb-sib.ch | isrec.isb-sib.ch | 83% | – | ||
genoviz.sourceforge.net | genoviz.sourceforge.net | 82% | – | ||
cgb.ki.se | cgb.ki.se | 82% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Eagle Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Eagle Genomics (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eagle Genomics
Complete news archive for Eagle Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eagle Genomics
Eagle Genomics was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Eagle Genomics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Anthony Finbow is the CEO of Eagle Genomics, as recorded in our data.
Eagle Genomics is a funded company, having raised a total of $38.73M across 9 funding rounds to date. The company's 1st funding round was a Seed of $917.7K, raised on Sep 2013.
Annual revenue of Eagle Genomics is $3.35M as on Mar 31, 2022.
Eagle Genomics was founded in 2008 and is based in Cambridge, United Kingdom. Cloud-based software solutions for genomic analysis are provided by the company within the biotechnology sector. Operations focus on platforms such as Eaglecore, which supports collaborative information management in research and development, and EagleEnsembl, which enables searching and analysis of genomic data. Services are delivered through a domain at eaglegenomics.com.
Eagle Genomics offers e[datascientist], e[exploration], e[biology], e[datascience], and 3 more products and services.
Eagle Genomics has 12 investors. Key investors include Gov.uk, Newable, abrdn, ETF Partners, and Granpool.
Eagle Genomics operates through Eagle Genomics Limited.